Chuan He1, Zhigang Liu1, Jie Ji1, Huanling Zhu1. 1. Department of Hematology, West China Hospital of Sichuan University Chengdu 610041, Sichuan, China.
Abstract
BACKGROUND AND OBJECTIVES: Numerous studies have focused on the role of survivin in non-Hodgkin's lymphomas (NHLs), but evidence regarding the prognostic value of survivin with respect to overall survival (OS) in NHL remains controversial. The aim of this study is to gain a better insight about the direct relationship between survivin expression and patients' survival statuses. MATERIALS AND METHODS: Relevant publications addressing the association between survivin expression and OS in NHL patients were selected from PubMed, Embase, Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure Database (CNKI), China Science and Technology Journal Database (VIP), Wanfang Database and the Cochrane library. Studies were pooled and summary hazard ratios (HR) were calculated. Sensitivity analyses and publication bias were also conducted. Statistical analysis was performed by STATA 12.0 software. RESULTS: 12 studies met the inclusion criteria. Combined HRs suggested that survivin overexpression had an unfavorable impact on NHL patients' survival (HR=1.55, 95% CI=1.12-2.13, P=0.008). Subgroup analyses according to the studies categorized by histological type, ethnicity, cutoff scores and follow-up period were also conducted, and all the above analyses supported the stability of the prognostic role of survivin. CONCLUSION: Our findings suggest that survivin high expression might be a poor prognostic factor for patients with NHL. However, further large scale studies are needed to confirm these findings.
BACKGROUND AND OBJECTIVES: Numerous studies have focused on the role of survivin in non-Hodgkin's lymphomas (NHLs), but evidence regarding the prognostic value of survivin with respect to overall survival (OS) in NHL remains controversial. The aim of this study is to gain a better insight about the direct relationship between survivin expression and patients' survival statuses. MATERIALS AND METHODS: Relevant publications addressing the association between survivin expression and OS in NHLpatients were selected from PubMed, Embase, Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure Database (CNKI), China Science and Technology Journal Database (VIP), Wanfang Database and the Cochrane library. Studies were pooled and summary hazard ratios (HR) were calculated. Sensitivity analyses and publication bias were also conducted. Statistical analysis was performed by STATA 12.0 software. RESULTS: 12 studies met the inclusion criteria. Combined HRs suggested that survivin overexpression had an unfavorable impact on NHLpatients' survival (HR=1.55, 95% CI=1.12-2.13, P=0.008). Subgroup analyses according to the studies categorized by histological type, ethnicity, cutoff scores and follow-up period were also conducted, and all the above analyses supported the stability of the prognostic role of survivin. CONCLUSION: Our findings suggest that survivin high expression might be a poor prognostic factor for patients with NHL. However, further large scale studies are needed to confirm these findings.
Authors: C Adida; C Haioun; P Gaulard; E Lepage; P Morel; J Briere; H Dombret; F Reyes; J Diebold; C Gisselbrecht; G Salles; D C Altieri; T J Molina Journal: Blood Date: 2000-09-01 Impact factor: 22.113
Authors: Spyridoula Vasileiou; Premal D Lulla; Ifigeneia Tzannou; Ayumi Watanabe; Manik Kuvalekar; Wendy L Callejas; Mrinalini Bilgi; Tao Wang; Mengfen J Wu; Rammurti Kamble; Carlos A Ramos; Rayne H Rouce; Zihua Zeng; Adrian P Gee; Bambi J Grilley; Juan F Vera; Catherine M Bollard; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Ann M Leen; George Carrum Journal: J Clin Oncol Date: 2021-01-28 Impact factor: 44.544